Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-394P (RNA, U6 small nuclear 394, pseudogene) is a human pseudogene derived from the U6 small nuclear RNA gene family. While the functional U6 snRNA participates in mRNA splicing as a component of the spliceosome, RNU6-394P itself does not encode a functional RNA molecule and lacks known protein products. Pseudogenes like RNU6-394P commonly arise from duplication or retrotransposition events. Although certain pseudogenes can have regulatory roles or be transcribed into noncoding RNAs affecting gene expression, there is currently no evidence indicating biological activity, disease relevance, or clinical significance for RNU6-394P[3][2][4]. This distinguishes it from the functional U6 snRNA, which is highly conserved and critical for splicing in eukaryotic cells[3][1]. If further information is required on functional U6 snRNA, see entries for "U6 small nuclear RNA" or related genes rather than this pseudogene.
None; there is no mechanism of action for drugs, as RNU6-394P is not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 394, pseudogene (RNU6-394P).